US to allow states to distribute Gilead’s remdesivir drug to fight COVID-19

(STL.News) The U.S. Department of Health and Human Services (HHS) said on Saturday it would allow state health departments to distribute Gilead Sciences Inc‘s remdesivir drug to fight COVID-19, and the United States would receive about 40% of the drug maker’s global donation.  Read HHS article on STL.News.

YouTube video courtesy of WION News